Literature DB >> 31982624

An epidemiological survey of the current status of Zika and the immune interaction between dengue and Zika infection in Southern Taiwan.

Wen-Hung Wang1, Aspiro Nayim Urbina2, Chia-Ching Wu3, Chih-Yen Lin4, Arunee Thitithanyanont5, Wanchai Assavalapsakul6, Po-Liang Lu7, Yen-Hsu Chen1, Sheng-Fan Wang8.   

Abstract

OBJECTIVES: This study was performed to examine the current status of Zika and the effects of pre-existing dengue immunity on Zika virus (ZIKV) infection in Southern Taiwan.
METHODS: A phylogenetic tree was used to analyze the phylogeny of detected ZIKVs. Paired sera from dengue patients were collected for the determination of dengue and Zika infection. Plaque reduction neutralization tests (PRNT) and quantitative reverse transcription PCR (qRT-PCR) were used to determine the titers of neutralizing antibodies and viruses, respectively. An antibody-dependent enhancement (ADE) assay was used to evaluate the effect of anti-dengue antibodies on ZIKV infection.
RESULTS: Epidemiological data indicated the continuous importation of ZIKV infection from neighboring Zika epidemic countries into Taiwan. A total of 78 dengue patients were enrolled and 21 paired serum samples were obtained. PRNT90 results for the 21 samples identified eight cases of primary dengue infection and 13 cases of secondary dengue infection; two samples were positive for ZIKV (MR766). Results from the ADE assay indicated that convalescent sera from primary and secondary dengue infection patients displayed significant ADE of the ZIKV infection when compared to healthy controls (p < 0.05).
CONCLUSIONS: This study suggests that pre-existing dengue immunity facilitates ZIKV infection and that the continuous importation of ZIKV infection may pose a threat to indigenous Zika emergence in Southern Taiwan.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antibody-dependent enhancement; Dengue; Importation; Plaque reduction neutralization test; Taiwan; Zika

Mesh:

Substances:

Year:  2020        PMID: 31982624     DOI: 10.1016/j.ijid.2020.01.031

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

Review 1.  Protection against dengue virus requires a sustained balance of antibody and T cell responses.

Authors:  Kristen M Valentine; Michael Croft; Sujan Shresta
Journal:  Curr Opin Virol       Date:  2020-08-13       Impact factor: 7.090

2.  A Live-Attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.

Authors:  Xianmiao Ye; Xinglong Liu; Ling Chen; Feng Li; Liqiang Feng; Tao Shu; Weiqi Deng; Min Liao; Yali Zheng; Xuehua Zheng; Xiaoyan Zhang; Ting Li; Wenxia Fan; Linbing Qu
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

3.  Climatic and socio-economic factors supporting the co-circulation of dengue, Zika and chikungunya in three different ecosystems in Colombia.

Authors:  Jasmine Morgan; Clare Strode; J Enrique Salcedo-Sora
Journal:  PLoS Negl Trop Dis       Date:  2021-03-11

4.  Post-Vaccination Yellow Fever Antiserum Reduces Zika Virus in Embryoid Bodies When Placental Cells are Present.

Authors:  Emily M Schultz; TyAnthony J Jones; Hannah K Hopkins; Jingmei Zeng; Kelli L Barr
Journal:  Vaccines (Basel)       Date:  2020-12-11

5.  Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015.

Authors:  Nicole Ngo-Giang-Huong; Charline Leroi; Dahlene Fusco; Tim R Cressey; Nantawan Wangsaeng; Nicolas Salvadori; Natedao Kongyai; Wasna Sirirungsi; Marc Lallemant; Prasert Auewarakul; Woottichai Khamduang; Gonzague Jourdain
Journal:  Viruses       Date:  2021-07-22       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.